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Abstract
Background: Although the WHO guideline for the management of dengue fever considers the presence of ascites
or pleural effusions in the diagnosis of DSS, it does not emphasize the importance of their presence when
selecting fluids for resuscitation.
Case presentation: We highlight three patients with DSS who received boluses of crystalloids on priority basis as
recommended by WHO guidelines during resuscitation. All three patients had varying degrees of third space fluid
loss (ascites and pleural effusions) at the time of development of DSS. Ascites and pleural effusions were detected
in all 3 patients at the time of shock irrespective of whether iv fluids were given or not. All three patients had
documented liver involvement at the time of shock evidenced by elevation of AST (4800 iu/L, 5000 iu/L and 1960
iu/L). One patient who had profound shock died 6 hours after admission with evidence of acute pulmonary
oedema in the convalescence phase. All of them needed CPAP ventilator support and potent diuretics.
Conclusions: We therefore feel that resuscitation of patients with DSS who already have third space fluid
accumulation with crystalloid boluses on priority basis may contribute to recovery phase pulmonary oedema.
Background
Dengue fever poses a major challenge to clinicians prac-
ticing in areas endemic for the infection. The presence
of four serotypes, immunity related subsequent enhance-
ment in severity, inadequate understanding of the
pathophysiology of severe infection [1,2], absence of spe-
cific treatment, overcrowding in hospitals, inadequate
laboratory facilities, delayed admissions due to patient
ignorance and delayed diagnosis all contribute to the
associated morbidity and mortality.
The diagnosis and management of severe dengue fever
(DF), dengue shock syndrome (DSS) and dengue hae-
morrhagic fever (DHF) are based mainly on clinical and
haematological parameters [3-5]. The WHO guidelines
which were practiced until September 2009 [3,4] and
the revised guideline which was published subsequently
[5], highlight the importance of packed cell volume
(PCV) and haemoglobin levels when deciding the quan-
tity and the type of fluid replacement. Although all
three guidelines consider third space fluid accumulation,
such as, pleural effusions and ascites, in the diagnosis of
DSS, they do not seem to emphasize their importance
in management [3-5].
The commonly used fluids in the management of
dengue fever include oral rehydration solutions (con-
taining solutes), intravenous solutions such as crystal-
loids (isotonic fluid replacement) and colloids (plasma
equivalents) [3-5]. The WHO guidelines in 1997 and
1999 recommend oral fluids and electrolyte therapy
during the febrile phase and in patients with excessive
sweating, vomiting and diarrhea, and those with evi-
d e n c eo fp l a s m al e a k a g ea sd i a g n o s e db yar i s ei nh a e -
moglobin and haematocrit. The guidelines recommend
fluid to be replaced initially with isotonic crystalloids
such as 0.9% normal saline and Ringers lactate solution,
which have equivalent composition to plasma fluid
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reproduction in any medium, provided the original work is properly cited.[3-5]. However, in cases with severe shock who do not
respond to initial isotonic crystalloids resuscitation need
to be treated with colloid solutions such as plasma or
plasma substitutes such as Dextran 40 (10% dextran of
medium related molecular mass in normal saline) or 5%
albumin [3,4].
The recent outbreak of dengue in Sri Lanka accounted
for more that 35000 cases and nearly 350 deaths (Epid
Unit Colombo; Unpublished data). Many deaths were
thought to be due to inappropriate fluid management
leading to fluid overload (WHO expert statement,
Colombo, Sri Lanka, Epid Unit Colombo; Unpublished
data), in addition to myocarditis related cardiac failure
and acute hepatic failure. We highlight three patients
who were admitted to our unit in various stages of den-
gue infection and developed DSS. Although they were
managed according to WHO guidelines [4] for fluid
management, they later developed recovery phase pul-
monary oedema resulting in extended morbidity in two
patients and death in one. We feel that these cases high-
l i g h tt h ei m p o r t a n c eo ft h i r ds p a c ef l u i dl o s sw h e n
replacing fluids in DSS, so that recovery phase fluid
overload and pulmonary oedema can be prevented.
Case presentation
A 19-year-old girl with a body weight of 48 Kg, who pre-
sented with fever for 5 days, vomiting, headache, body
aches and flushing developed dramatic reduction in
blood pressures from 100/70 mmHg to 80/40 in the
supine position, absent peripheral pulses and cold,
clammy extremities on day 6 of the illlness. She devel-
oped no bleeding manifestations during her illness.
Although she had an average Hb of 12.5 g/dl and a hae-
matocrit of 42.3% before the development of DSS, at the
time of development of DSS, she had a haematocrit of
55% with a Hb of 16 g/dl. She received 1.5 L of Ringers
Lactate solution and 1 L of Normal saline over the
48 hours prior to developing DSS because she had inter-
mittent vomiting during this period and she refused tak-
ing oral fluids and continued to vomit “all what she was
consuming” on clinical assessment she had varying
degrees of dehydration. Although such fluid replacement
is not recommended in the WHO guidelines in the man-
agement of dengue fever we were compelled to introduce
them purely on clinical grounds and on haemoglobin and
haematocrit values. This was in addition to 1.5 L of oral
fluid (consisting mainly of solutes; conjee and soup) over
t h es a m ep e r i o d“which she claimed to have vomited”.
Despite above management, she went into DSS very
acutely and at the time of development of DSS it was
n o t e dt h a ts h eh a dm o d e r a t ea s c i t e sa n das m a l lr i g h t
sided pleural effusion. She was then resuscitated primar-
ily with 3 intermittent boluses (10-20 ml/Kg/hr) [1
st
bolus (20 ml/Kg/Hr) over ~ 20 min (~320 ml), 2
nd bolus
( 1 0m l / K g / H r )o v e r~2 0m i n( ~ 1 6 0m l )a n dt h e
3
rd bolus (10 ml/Kg/Hr) over ~ 15 min (~120 ml); total
of ~ 600 ml] and at a rate of ~ 2-4 ml/Kg/Hr in between
boluses (~400 ml) of intravenous crystalloids amounting
to 1000 ml over two hours and then with colloids
(4 units of fresh frozen plasma ~100 ml × 4 = ~400 ml)
followed by 5 ml/Kg/Hr for ~ 4 hours (~960 ml) accord-
ing to 1999 WHO guidelines. We did not continue crys-
talloids in the same infusion rates for one hour as
recommended by the WHO guidelines, and instead man-
aged her with shorter duration boluses (15-20 min) due
to fairly rapid accumulation of fluid in the third space.
For the same reasons colloid solutions were instituted, as
suggested in previous studies [6], when her haematocrit
was increasing or was >50% in between fluid resuscita-
tions. Her haematocrit level was repeatedly monitored
during the 6 hours of resuscitation, and fluid manage-
ment was strictly based on haematocrit levels. Her serum
electrolytes, serum calcium, serum albumin and sugar
levels were within normal limits throughout her illness,
especially at the time she went into acute shock syn-
drome. Arterial blood gas analysis was not carried out
during the acute stage (due to practical reasons; no per-
ipheral arteries could be palpated, and more attention
was given for resuscitation). She had a minimum urine
output of 8 ml/hr for two hours during the period of
DSS, but output improved thereafter, and she had no bio-
chemical evidence of renal failure. She became mildly
confused and drowsy with hepatic transaminases rising
to very high levels (highest ALT- 1250 iu/L and highest
AST- 4800 iu/L) with an INR of 1.8. She was given intra-
venous N-acetylcysteine [7], intravenous vitamin K and
the liver failure regime (lactulose, metronidazole).
Although she recovered from DSS within six hours of
resuscitation, she developed progressive shortness of
breath at rest, and this was observed within the next two
hours. Her capillary oxygen saturation fell to 80 mmHg
while on 60% O2 by face mask. Her chest x-ray showed
severe pulmonary oedema with a right-sided pleural effu-
sion (Figure 1). She had no evidence of myocarditis or
other structural cardiac dis e a s eb yE C H Oc a r d i o g r a p h y ,
and had 60% ejection fraction at the time she developed
pulmonary oedema. Her CVP was 20 cmH2O. She was
commenced on continuous positive airway pressure
(CPAP) mask ventilation with 100% O2 combined with
intravenous frusemide, and showed gradual recovery over
72 hours (figure 2). Retrospective calculation reconfirmed
that the volume of fluid she had received during the DSS
phases of management were at volumes (in both oral and
iv fluids) recommended by the WHO guidelines [4].
The second patient, was a 26 year old mother of two
children with a body weight of 62 Kg who was admitted
to hospital with profound DSS, together with moderate
ascites and bilateral pleural effusions. Her systolic blood
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lic BP could not be recorded. The haemoglobin on
admission was 16 g/dl with a haematocrit of 58% and
the platelet count was 22,000/mm3 (these results were
only available after an hour of commencing resuscita-
tion). There was no evidence of bleeding. She had not
been treated with intravenous fluids before admission,
but was consuming oral fluids as advised by her general
practitioner (the exact volumes she had consumed were
not available as she had not maintained a fluid balance
chart). Her ECG showed sinus tachycardia and wide-
spraed T wave inversions, suggestive of myocarditis.
However, she had a 55% ejection fraction by ECHO car-
diography with no demonstrable underlying cardiac
pathology. She was managed with two intermittent
boluses (first bolus 20 ml/Kg/Hr over ~20 min amount-
ing to ~400 ml and the other bolus 20 ml/Kg/Hr over
another ~15 min amounting to ~300 ml) of intravenous
normal saline (her body weight was assumed as 60 kg,
as her body weight could not be measured as she was in
profound shock on admission) and the total amount of
crystalloids she had received was nearly 900 ml (Pre-
vious 700 ml + maintanence of 200 ml) during the first
two hours (total volume give was and colloids [6 units
o fF F P( 3×~ 1 0 0m l+3×~1 5 0m l )a m o u n t i n gt o
~750 ml)] over one hour. Fluid administration was
titrated based on the haematocrit values. Here again
short duration fluid boluses and colloids were given for
the same reasons as the first patient. Although her
blood pressures improved to 100/80 mm/Hg twice dur-
ing resuscitation (After each bolus of crystalloids com-
bined with colloids), this was not sustained. While being
resuscitated she developed respiratory distress with evi-
dence of pulmonary oedema in addition to bilateral
pleural effusions and required intubation and ventila-
tion. At the time she was transferred to the ICU for
ventilation her CVP was 22 cm H2Oa n dg r a d u a l l yr o s e
to 26 cm H2O when she died 6 hours after admission to
hospital. Her serum electrolytes were within normal lim-
its, but blood gas analysis, carried out 2 hours after
admission to the ICU, showed a mild metabolic acidosis.
Her blood glucose remained normal but liver functions
showed an AST of 5000 iu/L and ALT of 1600 iu/L.
This patient was not commenced on N-acetylcysteine or
the liver failure regime as she succumbed to her illness
within 6 hours of admission and the liver function test
results were available only after her death. The urine
out put was only 40 ml during the 6 hours hospital stay,
but the serum creatinine and blood urea were normal.
The serum calcium and cholesterol levels could not be
carried out in this patient. The post mortem showed
large amounts of blood stained ascites and pleural effu-
sions, congestion and widespread petecheal haemor-
rhages in all internal organs.
The third patient was a 32 year old female with a
body weight of 58 Kg who was admitted on the 4
th day
of her illness. She had not received intravenous fluids
prior to admission and had a systolic BP of 90 mmHg
and a diastolic BP of 80 mHg on admission, with a
small right sided pleural effusion and mild ascites. On
admission, her Hb was 17 g/dl and the PCV was 55, and
the platelet count was 15,000 mm3. She was initially
resuscitated with intravenous 0.9% saline 5-10 ml/Kg/Hr
for 4 hours in order to maintain the blood pressure and
she was advised to continue oral solutes thereafter. She
maintained good urine out put of nearly 40-50 ml/Hr
and had consumed nearly 1 L of oral solutes for the
next 24 hours. However, 24 hours after admission, she
developed profound shock with un-recordable systolic
Figure 1 Recovery phase pulmonary oedema with pleural
effusion.
Figure 2 Gradual improvement with CPAP mask ventilation.
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was 55 and she was intermittently resuscitated with
three boluses of Ringers lactate (~300 ml) and normal
saline solution [1
st bolus (20 ml/Kg/Hr) over ~ 15 min
(~300 ml), 2
nd bolus (10 ml/Kg/Hr) over ~ 15 min
(~150 ml) and the 3
rd bolus (20 ml/Kg/Hr) over ~ 20
min (~350 ml); total of ~ 600 ml] and at a rate of ~ 2-
4 ml/Kg/Hr in between boluses (~400 ml) during the
two hours of resuscitation (each bolus of fluid was
given over 15-20 min durations and it was tapered to
maintenance rates (5 ml/Kg/Hr or less) in between the
boluses [the total amount of fluid that had been admi-
nistered during this period was nearly 1200 ml], fol-
lowed by 4 units of FFP (~100 ml × 1 + ~150 ml × 3 =
~550 ml) and 4 units of platelets (~75 ml × 4 = ~300
ml) (total of ~850 ml). Fluid resuscitation in this patient
was also based on her haematocrit values. Her blood
pressure improved after fluid resuscitation. During the
two hours of shock stage she had urine out put of
50 ml and recovered thereafter. However, she rapidly
developed tense ascites, and subsequently developed
severe recovery phase pulmonary oedema and was trea-
ted with judicious amounts of intravenous frusemide,
taking care of her blood pressures. She never had bleed-
ing during the illness and her Hb and haematocrit
dropped to 13 g/dl and 43% respectively after resuscita-
tion. Her blood glucose, serum electrolytes and renal
function remained normal throughout the illness, and
AST and ALT levels were 1960 iu/L and 420 iu/L
respectively. Although her blood gas analysis showed
mild metabolic acidosis at the time she was sent to ICU
for ventilation, it gradually normalized on subsequent
monitoring. Her cardiac ejection fraction was 60% and
had no structural cardiac illness by ECHO cardiography.
Her CVP on admission to ICU was 18 cm H2O. Her
serum Ca and cholesterol levels were not assessed. She
was managed with CPAP ventilation similar to the first
patient.
All these patients had continuous monitoring for vital
signs, urine output and, when appropriate, haematocrit
values. Full blood counts were carried out either twice
daily or at an increased frequency when appropriate.
Liver function tests were carried out at the onset and at
the time of shock, and then as required for during fol-
low up. Blood gases were done in the first and third
patients at the time of the shock and when required
thereafter. Serum calcium levels were measured only in
the first patient and serum cholesterol levels were not
assessed. Patients were advised to avoid water and were
encouraged to take fluid containing electrolytes only.
However, we have no details as to whether the second
patient consumed water in excess amounts when she
was at home.
Conclusions
Two of our three patients had similar clinical and hae-
matological parameters when they developed DSS. How-
ever the patient who died had no haematological
investigations available at the time of presentation with
profound DSS. These three patients were managed
according to the WHO guidelines. We carried out most
of the appropriate investigations and used the fluid
management algorhythms. Although we used both crys-
talloids and colloids in the resuscitation of all three
patients, crystalloids were prioritized over colloids even
after the detection of third space fluid accumulation.
However, although the WHO guidelines recommend
fluid boluses at increased rates for one hour, we were
compelled to use shorter duration fluid boluses and
intermittent colloids as the patients were rapidly devel-
oping third space fluid accumulation in association with
an increase in haematocrit, suggesting continued fluid
leakage. Such continued fluid leakage could be due to
uncorrected hypoglycaemia, acidosis, low serum calcium,
lowering of serum albumin or due to administration of
either iv or oral hypotonic fluids in excess. The patient
who died had not received intravenous fluids prior to
admission, but she had been consuming extra fluids at
home, which is currently recommended for home based
management of DF. However the volume and the com-
position of fluid consumed had not been documented
by the patient. The other two patients did not receive iv
or extra oral fluids prior to or after admission. In all
three patients the blood sugar level remained normal. In
the first patient, the corrected serum calcium remained
normal and albumin level was low normal. In patients 1
and 3 there was only a mild metabolic acidosis. In the
second patient, some of these investigation results were
either not carried out or not available until very close to
her time of death. During the convalescence, all three
patients developed pulmonary oedema and reduced
arterial oxygen saturation requiring intensive care treat-
ment with ventilation. Observing the clinical features,
the management and the outcome of these three
patients, we hypothesize that resuscitation of patients
who already have third space fluid accumulation at the
time of development of severe DSS giving priority to
colloids rather than to crystalloids would prevent the
development of recovery phase pulmonary oedema.
Infections are a major cause of circulatory collapse in
children or adults [8]. However the controversy over the
choice of resuscitation solution, whether it is crystalloids
or colloids is yet to be resolved [8,9]. Although there are
several studies that has been performed in order to
address this issue in both children and adults, most
these studies seem to depend on parameters such as
blood pressure, pulse rate, capillary filling time, pulse
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volume in the diagnosis and evaluation of treatment out-
c o m e s[ 1 0 , 1 1 ] .T h e yd on o tc o n s i d e rt h ep r e s e n c eo f
third space fluid loss as an important determinant in
order to select the resuscitation fluids. Although the
pathophysiology of shock syndrome due to most infec-
tions is similar [9], the shock syndrome in DF is transient
and reverses rapidly [3-5]. Therefore, patients who devel-
oped third space fluid loss during shock stage are very
likely to be at risk of rapid circulatory overload during
the recovery phase. There is one randomized controlled
trial that highlights the advantage of colloids over crystal-
loids in the management of DSS in children [11]
All these patients were assessed and resuscitated
according to WHO guidelines for the management of
dengue fever [4]. As highlighted in the WHO guidelines,
there is no doubt that haematological parameters such
as Hb and haematocrit, and assessment for evidence for
third space fluid loss such as the presence of ascites and
pleural effusions are very important in diagnosing early
fluid leakage and subsequent intravascular volume loss.
However the guidelines do not pay much attention to
the presence of third space fluid accumulation when
selecting appropriate intravenous fluids for resuscitation
[3-5]. We wonder whether resuscitation of intravascular
volume in patients who develop DSS in the presence of
ascites and pleural effusions, giving priority to colloid
boluses instead of crystalloid boluses would prevent
fluid overload related morbidity and mortality in the
recovery phase. This is because, crystalloids (normal sal-
ine) increases the extracellular fluid compartment 1:1
ratio with only 20% remaining with the intravascular
space, whereas 5% albumin increases extracellular fluid
more than twice and is distributed equally intravascu-
larly and interstitially [12]. Therefore, volume to volume,
two to three times as much crystalloids need to be used
as colloid for the same haemodynamic effect. Further-
more, a higher incidence of pulmonary oedema has
been reported in patients with hypovolemic and septic
shock receiving saline, which was attributed to a fall in
colloid osmotic pressure [13]. Therefore, replacing crys-
talloids with colloid solutions, such as FFP, may reduce
recovery phase pulmonary oedema by improving osmo-
tic pressure resulting in minimizing leakage of fluid to
the extravascular compartment. Furthermore, such
improvement in oncotic pressure would also help in the
gradual re-absorption of ascites and pleural effusions.
This may also reduce requirements for intravenous crys-
talloids in the management of DSS.
A previous double blind randomized clinical trial con-
ducted in children with moderately severe DSS has
shown that there was no significant difference in the
development of new bleeding manifestations, clinical
fluid overload, objective measures of the overall severity
of vascular leakage (right pleural effusion, ascites), or the
use of furosemide whether they were initially resuscitated
with crystalloids or colloids [6]. However, in this study,
the presence of third space fluid accumulation at the
time of recruitment to the study is not mentioned.
Furthermore, the study does not randomize patients with
severe dengue shock syndrome to treatment with crystal-
loids because of concerns about the potential develop-
ment of critical fluid overload without access to
advanced respiratory support. However, more patients
with severe shock at presentation had required rescue
colloids than did patients with moderately severe shock.
The article also highlights the finding that the effect of
colloids in preventing fluid leakage lasts only a few hours.
However it concludes that for those with severe shock,
the situation is less clear-cut and that clinicians must
continue to rely on personal experience, familiarity with
particular products, local availability, and cost. Minor
advantages in initial recovery were shown with starch,
and significantly more adverse reactions were associated
with dextran, so that if the use of a colloid is considered
necessary, starch may be the preferred option.
In conclusion, we recommend that our observation,
that resuscitation of patients with DSS who already have
third space fluid accumulation with crystalloid boluses
on a priority basis may contribute to recovery phase
pulmonary oedema, needs to be further tested by rando-
mized control trials recruiting patients with severe DSS
who have already developed third space fluid accumula-
tion. Use of colloids such as FFP could be investigated
in such trials, keeping in mind possible transfusion reac-
tions with FFP and reactions to artificial colloids while
they are being administered.
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